Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Vaccines topic
No spam. Unsubscribe anytime.
Sen. Cassidy, a physician, defends vaccines and warns against reshaped advisory panel messaging
Summary
Sen. Bill Cassidy said vaccines are "safe and effective," recounted seeing deaths from vaccine-preventable disease, and criticized some rationales used by an advisory panel he said has been reshaped under appointees tied to RFK Jr.; he urged parents to consult pediatricians and noted the transcript's reference to a health secretary statement after two measles deaths in West Texas.
Get email alerts on the Vaccines topic
No spam. Unsubscribe anytime.
Sen. Bill Cassidy (R-La.), who noted his medical background on the program, strongly defended routine immunization and pushed back on what he described as misleading messaging from a reshaped vaccine advisory process.
Cassidy said, "vaccines are safe and effective," and recounted clinical experience: "I have seen children and adults die from vaccine-preventable diseases." He criticized elements of the advisory committee's recent rationale and said he was uncomfortable with some of the panel's decisions after appointees associated with Robert F. Kennedy Jr. exerted influence, as discussed in recent hearings.
The transcript also records Cassidy saying the president has publicly supported immunization at times and cited Operation Warp Speed as an achievement that accelerated vaccine development. Cassidy referenced that, after two children died in West Texas, the health department official mentioned on the program (referred to in the transcript as "Secretary Kennedy") recommended vaccination; the interview itself did not include the health secretary's direct remarks.
Cassidy told parents to speak with their pediatrician and stressed that changes to advisory panels should not erode public confidence in vaccines. The segment presented Cassidy's views and experiences; it did not include on-air responses from public health agencies or members of the advisory panel.

